Cyclic Peptides News Today

To understand the focus of startup Insamo Inc., one need look no further than its name, which co-founder and CEO Timothy Craven described as “portmanteau of ‘internally satisfied molecules,’” highlighting its efforts to create orally administered and membrane-permeable cyclic peptides across a range of disease areas.

Cyclic peptides, with their unique binding capacity, intrigue drug developers by tackling challenging targets, surpassing traditional drug-making hurdles.

/PRNewswire/ -- The "Global Peptide Therapeutics Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering. To date,...

The fourth edition incorporating the first and second addenda, of the World Health Organization’s (WHO) Guidelines for drinking-water quality (GDWQ) builds on over 60 years of guidance by WHO on drinking-water quality, which has formed an authoritative basis for the setting of national regulations and standards for water safety in support of